Žiga Rotar

2.3k total citations
75 papers, 850 citations indexed

About

Žiga Rotar is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Žiga Rotar has authored 75 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Rheumatology, 30 papers in Pulmonary and Respiratory Medicine and 15 papers in Genetics. Recurrent topics in Žiga Rotar's work include Vasculitis and related conditions (29 papers), Rheumatoid Arthritis Research and Therapies (23 papers) and Systemic Lupus Erythematosus Research (17 papers). Žiga Rotar is often cited by papers focused on Vasculitis and related conditions (29 papers), Rheumatoid Arthritis Research and Therapies (23 papers) and Systemic Lupus Erythematosus Research (17 papers). Žiga Rotar collaborates with scholars based in Slovenia, Switzerland and Finland. Žiga Rotar's co-authors include Matija Tomšič, Alojzija Hočevar, Rok Ješe, Saša Čučnik, Vesna Júrčić, Sonja Praprotnik, Jože Pižem, Polona Žigon, Alenka Vizjak and Katja Lakota and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Žiga Rotar

70 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Žiga Rotar Slovenia	18	547	433	168	147	125	75	850
G. Maigné France	15	362 0.7×	451 1.0×	132 0.8×	230 1.6×	110 0.9×	37	723
H. Devilliers France	17	637 1.2×	405 0.9×	209 1.2×	96 0.7×	115 0.9×	69	990
Lillian Barra Canada	18	658 1.2×	373 0.9×	322 1.9×	99 0.7×	89 0.7×	53	1.2k
Daiki Nakagomi Japan	16	470 0.9×	355 0.8×	181 1.1×	104 0.7×	105 0.8×	61	906
T. Quéméneur France	13	326 0.6×	408 0.9×	102 0.6×	154 1.0×	50 0.4×	41	638
A. González Piñeiro Spain	10	784 1.4×	566 1.3×	195 1.2×	168 1.1×	58 0.5×	19	1.1k
Maria Letizia Urban Italy	21	611 1.1×	348 0.8×	224 1.3×	88 0.6×	77 0.6×	53	1.1k
Fausta Catapano Italy	10	375 0.7×	326 0.8×	260 1.5×	211 1.4×	86 0.7×	18	831
Carla Maldini France	13	525 1.0×	532 1.2×	90 0.5×	53 0.4×	99 0.8×	20	1.0k
Caroline Roozendaal Netherlands	17	342 0.6×	303 0.7×	261 1.6×	96 0.7×	44 0.4×	37	906

Countries citing papers authored by Žiga Rotar

Since Specialization

Citations

This map shows the geographic impact of Žiga Rotar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Žiga Rotar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Žiga Rotar more than expected).

Fields of papers citing papers by Žiga Rotar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Žiga Rotar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Žiga Rotar. The network helps show where Žiga Rotar may publish in the future.

Co-authorship network of co-authors of Žiga Rotar

This figure shows the co-authorship network connecting the top 25 collaborators of Žiga Rotar. A scholar is included among the top collaborators of Žiga Rotar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Žiga Rotar. Žiga Rotar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paul, D. McK., et al.. (2023). POS0626 PERTURBED LIPID METABOLISM IS A CENTRAL METABOLIC REPROGRAMMING HUB IN SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases. 82. 587–587.

Hočevar, Alojzija, et al.. (2023). Short-term outcome of patients with adult IgA vasculitis: a single-center experience. Frontiers in Medicine. 10. 1210307–1210307. 5 indexed citations

Courvoisier, Delphine S., Kim Lauper, Joanna Kedra, et al.. (2022). EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology. Annals of the Rheumatic Diseases. 81(6). 780–785. 12 indexed citations

Žigon, Polona, Snežna Sodin‐Šemrl, Mirjana Zlatković‐Švenda, et al.. (2022). Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2. International Journal of Molecular Sciences. 24(1). 211–211. 5 indexed citations

Ješe, Rok, et al.. (2022). COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia. Clinical Rheumatology. 41(8). 2449–2456. 6 indexed citations

Rotar, Žiga, et al.. (2022). Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study. Frontiers in Medicine. 9. 1069013–1069013. 10 indexed citations

Kuret, Tadeja, Katja Lakota, Saša Čučnik, et al.. (2021). Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis. International Journal of Molecular Sciences. 22(12). 6520–6520. 10 indexed citations

Lauper, Kim, Joanna Kedra, Maarten de Wit, et al.. (2021). Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology. RMD Open. 7(3). e001818–e001818. 4 indexed citations

Lakota, Katja, Katja Perdan Pirkmajer, Alojzija Hočevar, et al.. (2021). COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases. Frontiers in Immunology. 11. 611318–611318. 16 indexed citations

10.

Rotar, Žiga, et al.. (2020). Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study. BMJ Open. 10(2). e034356–e034356. 9 indexed citations

11.

Hočevar, Alojzija, Matija Tomšič, Vesna Júrčić, Katja Perdan Pirkmajer, & Žiga Rotar. (2019). Predicting gastrointestinal and renal involvement in adult IgA vasculitis. Arthritis Research & Therapy. 21(1). 302–302. 29 indexed citations

12.

Lauper, Kim, Denis Mongin, Florenzo Iannone, et al.. (2019). Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 50(1). 17–24. 18 indexed citations

13.

Rotar, Žiga, et al.. (2018). The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs—BioRx.si. Clinical Rheumatology. 38(2). 297–305. 12 indexed citations

14.

Feichtinger, Julia, Katja Lakota, Gerhard Thallinger, et al.. (2018). Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients. Clinical Rheumatology. 38(2). 317–329. 34 indexed citations

15.

Hočevar, Alojzija, et al.. (2018). The incidence of idiopathic inflammatory myopathies in the adult Slovenian population. Clinical Rheumatology. 38(2). 279–283. 3 indexed citations

16.

Hočevar, Alojzija, et al.. (2018). Antiphospholipid antibodies in adult IgA vasculitis: observational study. Clinical Rheumatology. 38(2). 347–351. 4 indexed citations

17.

Kuret, Tadeja, Katja Lakota, Žiga Rotar, et al.. (2017). A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods. Autoimmunity Reviews. 17(2). 188–194. 17 indexed citations

18.

Chatzidionysiou, Katerina, Elisabeth Lie, G. Lukina, et al.. (2017). Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. The Journal of Rheumatology. 44(2). 162–169. 16 indexed citations

19.

Rotar, Žiga, et al.. (2016). The Persistence of Golimumab in Daily Clinical Practice for the Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: Analysis of Prospectively Collected Data in the Slovenian National Online Registry of Patients Treated with Biologics. Value in Health. 19(3). A228–A228. 2 indexed citations

20.

Sillat, Tarvo, Pauliina Porola, Arno Hänninen, et al.. (2012). Brief Report: First identification of H₄ histamine receptor in healthy salivary glands and in focal sialadenitis in Sjögren's syndrome. Arthritis & Rheumatism. 64(8). 2663–2668. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact